메뉴 건너뛰기




Volumn 103, Issue 2, 2012, Pages 145-149

Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark

Author keywords

Antenatal prophylaxis; Cell free fetal DNA; Compliance; RHD genotyping

Indexed keywords

RHESUS D ANTIBODY;

EID: 84864002104     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2012.01602.x     Document Type: Article
Times cited : (10)

References (6)
  • 1
    • 48249088516 scopus 로고    scopus 로고
    • One single dose of 200μg of antenatal RhIG halves the risk of anti-D-immunization and hemolytic disease of the fetus and newborn in the next pregnancy
    • Koelewijn JM, de Haas M, Vrijkotte TG, et al. : One single dose of 200μg of antenatal RhIG halves the risk of anti-D-immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion 2008; 48:1721-1729
    • (2008) Transfusion , vol.48 , pp. 1721-1729
    • Koelewijn, J.M.1    de Haas, M.2    Vrijkotte, T.G.3
  • 2
    • 84863996572 scopus 로고    scopus 로고
    • Anti-D administration in pregnancy for preventing Rhesus alloimmunization (Cochrane review) I. The Cochrane Library.
    • Crowther C: Anti-D administration in pregnancy for preventing Rhesus alloimmunization (Cochrane review) I. The Cochrane Library, issue 2, 2004
    • (2004) , Issue.2
    • Crowther, C.1
  • 4
    • 84859757903 scopus 로고    scopus 로고
    • Report of the first nationally implemented clinical routine screening for fetal RHD in RhD negative women to ascertain the requirement for antenatal RhD prophylaxis
    • Epub Oct. 13. doi: 10.1111/j.1537-2995.2011.03362.x.
    • Clausen FB, Christiansen M, Steffensen R, et al. : Report of the first nationally implemented clinical routine screening for fetal RHD in RhD negative women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 2011. Epub Oct. 13. doi: 10.1111/j.1537-2995.2011.03362.x.
    • (2011) Transfusion
    • Clausen, F.B.1    Christiansen, M.2    Steffensen, R.3
  • 5
    • 10344262881 scopus 로고    scopus 로고
    • Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of hemolytic disease of the fetus and newborn
    • Daniels G, Finning K, Martin P, et al. : Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of hemolytic disease of the fetus and newborn. Vox Sang 2004; 87:225-232
    • (2004) Vox Sang , vol.87 , pp. 225-232
    • Daniels, G.1    Finning, K.2    Martin, P.3
  • 6
    • 0031794234 scopus 로고    scopus 로고
    • The scientific basis of antenatal prophylaxis
    • Urbaniak SJ: The scientific basis of antenatal prophylaxis. BJOG 1998; 105:11-18
    • (1998) BJOG , vol.105 , pp. 11-18
    • Urbaniak, S.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.